Login / Signup

Expression of Podocalyxin Potentially Decorated With Low-sulfated Keratan Sulfate in Human Testicular Embryonal Carcinoma.

Akifumi MuramotoHitomi HoshinoAkifumi MuramotoMasataka MurahashiTomoya O AkamaNaoki TeradaMotohiro Kobayashi
Published in: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society (2024)
SummaryWe previously demonstrated that among various histological types of human testicular germinal cell tumors (GCTs), embryonal carcinoma (EC) preferentially expresses low-sulfated keratan sulfate (KS) consisting of repeating N -acetyllactosamine (LacNAc) disaccharide units composed of galactose and 6- O -sulfated N -acetylglucosamine (GlcNAc), which is recognized by the R-10G antibody. Recently, we generated another anti-low-sulfated KS monoclonal antibody, 294-1B1. Immunohistochemical analysis of testicular GCTs ( n =83) revealed that the low-sulfated KS recognized by 294-1B1 is also preferentially expressed in EC but minimally in other GCT histological types. Moreover, immunolabeling with R-10G and 294-1B1 antibodies was resistant to peptide- N -glycosidase F digestion, and EC was not stained with the MECA-79 antibody, indicating that low-sulfated KS expressed in EC contains mucin-type core 2 O -glycans carrying GlcNAc-6- O -sulfated oligo-LacNAc. Double immunofluorescence staining showed that R-10G and 294-1B1 antibody signals colocalized with those for podocalyxin (PODXL). Furthermore, western blot analysis of recombinant human PODXL•IgG fusion proteins secreted from low-sulfated KS-expressing human embryonic kidney 293T cells revealed that PODXL functions as a core protein for low-sulfated KS. Taken together, these findings strongly suggest that the PODXL glycoform decorated with low-sulfated KS is preferentially expressed in human testicular EC and may therefore serve as a diagnostic marker for this malignancy.
Keyphrases
  • endothelial cells
  • single cell
  • stem cells
  • induced pluripotent stem cells
  • pluripotent stem cells
  • bone marrow
  • mesenchymal stem cells
  • cell therapy
  • quantum dots
  • binding protein